Pharma News

Pharmaceutical company Viatris will acquire the eye disease drug developers Oyster Point Pharma and Famy Life Sciences in separate deals announced Monday.  ...

The FDA has placed a hold on Verve Therapeutics’ Investigational New Drug (IND) application to conduct a clinical trial evaluating the company’s VERVE-101 gene editing treatment to inactivate a...

Study shows combining brentuximab vedotin with the standard chemotherapy regimen reduced the risk of relapse in children with high-risk Hodgkin lymphoma by 10%. ...

The company’s BCMA-targeted Blenrep has failed a phase 3 trial in relapsed or refractory multiple myeloma. The GSK antibody-drug conjugate didn’t outdo Bristol Myers Squibb’s Pomalyst and low...

AstraZeneca and Sanofi have secured approval in the EU for Beyfortus, the first single-dose drug to protect newborns and infants from respiratory syncytial virus (RSV) infections. ...

The FDA handed Lupin a warning letter citing the company’s failure to correct cross-contamination issues noted in an inspection of its manufacturing plant in Palghar, India, earlier this year. ...

A new study, led by experts at the University of Nottingham found that the risk of stomach bleeding caused by using aspirin long-term, can be reduced with a short course of antibiotics, potentially...

The funds will be used for the Phase III clinical trial of ecopipam for treating Tourette syndrome patients.

For $200 million up front and a possible $4.3 billion later, Arcturus Therapeutics has agreed to a vaccine collaboration with CSL Seqirus.

HLB's U.S subsidiary, Immunomic Therapeutics, gets FDA fast track designation for Merkel cell cancer therapeutic, ITI-3000.

The FDA has issued a Deferred Action letter for Amicus Therapeutics’ biologic license application (BLA) for cipaglucosidase alfa, the biologic component of AT-GAA, its investigational dual therap...

Research led by Dr. Mabel Vidal in the Department of Computer Science at the University of Concepcion, with the collaboration of researchers from MELISA Institute and other academic institutions, i...